Elligo Health unveils new clinical trials technology
Elligo Health Research has unveiled new IntElligo Research Stack clinical technology designed to...
Trending menu:
Most Read
Latest Content
Medable unveils telemedicine solution only for clinical trials
US-based Medable has unveiled a telemedicine solution designed only for clinical trials.
Broader inclusion criteria to double eligible cancer patients for clinical trials, finds study
A study assessing the health records of more than 10,500 patients with advanced non-small cell lung cancer (aNSCLC) from ASCO’s CancerLinQ database found that the use of expanded clinical trial inclusion criteria would nearly double the percentage of eligible cancer patients to enroll in clinical trials.
Massive Bio teams up with Biden Cancer Initiative to boost oncology clinical trials access
Massive Bio, a US-based provider of precision medicine and patient centric clinical trial matching services, has partnered in the Biden Cancer Initiative’s Oncology Clinical Trial Information Commons (OCTIC).
Tempus introduces TIME trial service to match cancer patients to clinical trials
Medical technology company Tempus has launched a new service that uses artificial intelligence to quickly match cancer patients to clinical trials.
Healthcare organisations release common cancer data standards to improve patient care
The American Society of Clinical Oncology (ASCO) and its nonprofit subsidiary, CancerLinQ LLC, The MITRE Corporation, and the Alliance for Clinical Trials in Oncology Foundation are collaborating to advance cancer data sharing and to improve patient care.
WCG offers data-driven benchmarking solution for medical device companies
WIRB-Copernicus Group’s (WCG) clinical services division has introduced its data-driven benchmarking solution to medical device companies.
ActiGraph and VivoSense partner to provide secure access to regulated sensor data
ActiGraph has announced its partnership with VivoSense to enhance secure access to regulated sensor data from patients in pharmaceutical clinical trials.
Alphabet’s Verily forms strategic alliance with Novartis, Pfizer, Otsuka and Sanofi
Verily, a subsidiary of Alphabet company, has formed a strategic alliance with Novartis, Pfizer, Otsuka and Sanofi to transform clinical research.
Latest News
Go Top
